LUND, Sweden--(BUSINESS WIRE)--Reglatory News:
Probi (STO:PROB)
Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd., based in Seoul, South Korea for the distribution of Probi´s gut health product, Probi Mage®. The Product will be launched under Probi’s brand in South Korea in the second quarter of 2014.
Help employers find you! Check out all the jobs and post your resume.
